Cost-effectiveness of different strategies for screening and treatment of Strongyloides stercoralis in migrants from endemic countries to the European Union.
Philip Erick Wikman JogersenJara Llenas-GarciaJad ShedrawyJoaquim GasconJose MuñozZeno BisoffiAna Requena-MendezPublished in: BMJ global health (2021)
Presumptively treating all immunosuppressed migrants from areas with endemic Strongyloides would generate cost savings to the health system.
Keyphrases